NCT03604315View on ClinicalTrials.gov

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

PHASE1RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Breast CarcinomaFallopian Tube CarcinomaOvarian CarcinomaPrimary Peritoneal CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaSolid Neoplasm
Interventions
PROCEDURE

Computed Tomography

Undergo FDG PET/CT

PROCEDURE

Computed Tomography

Undergo \[18F\]FTT PET/CT

RADIATION

Fludeoxyglucose F-18

Given IV

RADIATION

Fluorine F 18 Fluorthanatrace

Given IV

PROCEDURE

Positron Emission Tomography

Undergo FDG PET/CT

PROCEDURE

Positron Emission Tomography

Undergo \[18F\]FTT PET/CT

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03604315 - Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF | Biotech Hunter | Biotech Hunter